A zebrafish model of diabetic nephropathy shows hyperglycemia, proteinuria and activation of the PI3K/Akt pathway
Disease Models & Mechanisms · 01.05.2024 · 17 (5)
DOI: 10.1242/dmm.050438 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, online erschienen am 29.05.2024. Verfasst von Liqing Zang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Regional Innovation Studies, Mie University, Tsu, Mie 514-8507, Japan. Hauptthemen laut MEDLINE: Zebrafish, Hyperglycemia, Proto-Oncogene Proteins c-akt, Diabetic Nephropathies. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Mie University.
Abstract (Originalsprache)
Diabetic nephropathy (DN), as a complication of diabetes, is a substantial healthcare challenge owing to the high risk of morbidity and mortality involved. Although significant progress has been made in understanding the pathogenesis of DN, more efficient models are required to develop new therapeutics. Here, we created a DN model in zebrafish by crossing diabetic Tg(acta1:dnIGF1R-EGFP) and proteinuria-tracing Tg(l-fabp::VDBP-GFP) lines, named zMIR/VDBP. Overfed adult zMIR/VDBP fish developed severe hyperglycemia and proteinuria, which were not observed in wild-type zebrafish. Renal histopathology revealed human DN-like characteristics, such as glomerular basement membrane thickening, foot process effacement and glomerular sclerosis. Glomerular dysfunction was restored upon calorie restriction. RNA sequencing analysis demonstrated that DN zebrafish kidneys exhibited transcriptional patterns similar to those seen in human DN pathogenesis. Notably, the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway was activated, a phenomenon observed in the early phase of human DN. In addition, metformin improved hyperglycemia and proteinuria in DN zebrafish by modulating Akt phosphorylation. Our results indicate that zMIR/VDBP fish are suitable for elucidating the mechanisms underlying human DN and could be a powerful tool for therapeutic discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Regional Innovation Studies, Mie University, Tsu, Mie 514-8507, Japan.
- Mie University Zebrafish Research Center, Tsu, Mie 514-8507, Japan.
- Department of Biomedical Molecular Sciences (Anatomy II), Fujita Health University School of Medicine, Toyoake 470-1192, Japan.
- Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu, Mie 514-8507, Japan.
- Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York City, NY 10029-5674, USA.
- Department of Integrative Pharmacology, Mie University Graduate School of Medicine, Tsu, Mie 514-8507, Japan.
ORCID-Profile: Liqing Zang, Weibin Zhou, Yasuhito Shimada
Förderung
- Japan Society for the Promotion of Science
- Mie University
Zitieren
APA
Zang, L., Saitoh, S., Katayama, K., Zhou, W., Nishimura, N., & Shimada, Y. (2024). A zebrafish model of diabetic nephropathy shows hyperglycemia, proteinuria and activation of the PI3K/Akt pathway. Disease Models & Mechanisms, 17(5). https://doi.org/10.1242/dmm.050438
Vancouver
Zang L, Saitoh S, Katayama K, Zhou W, Nishimura N, Shimada Y. A zebrafish model of diabetic nephropathy shows hyperglycemia, proteinuria and activation of the PI3K/Akt pathway. Disease Models & Mechanisms. 2024;17(5). doi:10.1242/dmm.050438
BibTeX
@article{Zang2024,
author = {Zang, Liqing and Saitoh, Sei and Katayama, Kan and Zhou, Weibin and Nishimura, Norihiro and Shimada, Yasuhito},
title = {A zebrafish model of diabetic nephropathy shows hyperglycemia, proteinuria and activation of the PI3K/Akt pathway},
journal = {Disease Models & Mechanisms},
year = {2024},
volume = {17},
number = {5},
doi = {10.1242/dmm.050438}
}
EUVIMED